This page was reviewed under our medical and editorial policy by
Maurie Markman, MD, President, Medicine & Science at CTCA.
This page was updated on July 20, 2022.
Intestinal cancer, also known as small intestine cancer or small bowel cancer, is very rare, accounting for less than 1 percent of all new cancer diagnoses. Stretched out, the small intestine is about 21 feet long and comprises a large part of the digestive system. Still, it accounts for only 10 percent of all gastrointestinal cancers.
The American Cancer Society estimates approximately 11,790 people in the United States will be diagnosed with small intestine cancer in 2022.
Intestinal cancer is such an important focus at Cancer Treatment Centers of America® (CTCA) that each of our hospitals has a GI Cancer Center dedicated to treating patients with all stages of gastrointestinal diseases. Our gastroenterologists and oncologists understand the complexities of intestinal cancer and the array of treatment options available to you, including the Whipple procedure, segmental resection (hemicolectomy) and palliative procedures.
We also offer supportive care services to manage side effects before, during and after treatment. This overview will cover the basic facts about intestinal cancer, including:
If you believe you may be experiencing symptoms of intestinal cancer and want to schedule an appointment for diagnostic testing, or if you’re interested in a second opinion on your intestinal cancer diagnosis and treatment plan, call us or chat online with a member of our team.
The cause of small intestine cancer is not well understood. Some diseases, practices and inherited conditions that are risk factors for the disease include:
Statistics show that intestinal cancer risk is slightly higher for men than women. Nearly a third of all cases are diagnosed in patients older than 65, and the average age of diagnosis is 67.
People who smoke or drink alcohol, who have gastrointestinal conditions or cancers or who have certain inherited diseases are at increased risk of developing intestinal cancer.
"I remember a conversation I had with my medical oncologist in the first year I was going through treatment at CTCA. I told him, 'I'm not going to make it to deer camp this year.' I was bummed. But he assured me I was well on my way to getting better. He said, 'You'll be at deer camp next year.' The next November, I went up to deer camp and harvested the biggest deer of my life."
Intestinal cancer, also called small intestine cancer or small bowel cancer, usually starts in the lining of the small intestine and may spread from the digestive system to other parts of the body. Most cases of intestinal cancer develop in the duodenum, or upper part of the small intestine.
The main types of cancer in the small intestine include:
Tumors in the small intestine may block the flow of food and affect digestion. As the tumor gets bigger, the blockages may cause pain in the abdomen. A slowly bleeding tumor may lead to anemia. Digested blood may cause the stool to become black or tarry. An obstruction—when the flow of food is completely blocked—may cause intense pain, nausea and vomiting and typically requires immediate surgery.
In general, however, intestinal cancer symptoms are often vague and difficult to diagnose. Small tumors in an early stage may not cause apparent symptoms until the cancer spreads, making early detection difficult. High-risk patients should develop a cancer prevention plan that involves regular screenings.
The common symptoms of intestinal cancer include:
Tools and procedures used for intestinal cancer screening and diagnosis include:
Learn more about diagnostic procedures for intestinal cancer
We target intestinal tumors with sophisticated, evidence-based treatments and technology. Your multidisciplinary team of oncologists and gastroenterologists will answer your questions and recommend treatment options based on your unique diagnosis and needs. Common treatments for intestinal cancer include:
At CTCA, we understand that intestinal cancer and other malignancies of the gastrointestinal tract create unique challenges for patients, and that treatment options are very specific to each disease. That’s why each CTCA hospital has a GI Cancer Center dedicated to diagnosing, treating and supporting the quality of life of patients with intestinal and other GI cancers. The clinicians at each of our GI Cancer Centers are committed to offering state-of-the-art treatments for patients with gastrointestinal cancer. Our multidisciplinary team of board-certified medical oncologists, radiation oncologists and gastroenterologists work together with our integrative care providers and each patient to deliver clinical care with a patient-centered approach. After your diagnosis is confirmed, our GI Cancer Center care team will discuss your options with you and help you develop a personalized care plan tailored to your individual needs.
Because of the digestive tract’s role in processing food and waste, many patients with gastrointestinal disease have difficulty with digestive function. That’s why nutrition therapy is a key component of our GI Cancer Centers’ approach. The centers each have a dedicated dietitian on staff to work with patients in developing a healthy, balanced and appetizing nutrition plan. If patients become malnourished, the dietitian is available to help them establish healthy lifestyle and eating habits to help improve their condition.
The GI Cancer Center teams also work closely with other supportive care clinicians to manage additional disease- and treatment-related side effects, such as nausea and vomiting. These supportive care experts may include a pain management physician, as well as naturopathic, behavioral health and spiritual support providers.
Qualified patients are also offered carefully selected clinical trials. Your care team will discuss whether you qualify for any of our ongoing clinical trials and, if so, help you enroll.
Supportive care therapies that may be recommended to help intestinal cancer patients stay strong and maintain their quality of life include:
